Alkermes Investigational Site

Allentown, Pennsylvania 18104

0 studies enrolling now · 6 studies all time

What they study most

Major Depressive Disorder, Refractory Major Depressive Disorder, Schizophrenia

Studies at this site

• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) — Stopped early
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) — Completed
• A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD) — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed